Ryan David Lake - 31 Jan 2022 Form 4 Insider Report for Recro Pharma, Inc.

Signature
By: Ryan D. Lake
Issuer symbol
N/A
Transactions as of
31 Jan 2022
Net transactions value
-$2,185
Form type
4
Filing time
02 Feb 2022, 15:30:17 UTC
Previous filing
24 Jan 2022
Next filing
04 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCTL Common Stock Tax liability $2,185 -1,419 -0.26% $1.54 545,774 31 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Company to satisfy applicable withholding taxes upon vesting of restricted stock units.